Saffola and the Consumer Shift Toward Preventive Health

Industry & Competitive Context

India’s edible oil and packaged foods industry has historically competed on price, taste, and regional preference rather than health outcomes. Within this category, Marico Limited (NSE: MARICO, BSE: 531642) built Saffola into what multiple industry case studies describe as a health-care brand operating inside the edible oils business rather than a conventional cooking oil brand competing on commodity attributes. Marico’s own corporate materials describe Saffola as “a synonym with preventive health care.”

The brand’s origins trace to the 1960s, when Saffola was launched as an edible oil. Marico recognised considerable growth potential in the edible oil category and initiated a strategic focus on developing the Saffola brand, promoting it as an oil for a healthy heart. Ownership of the brand moved to Marico in stages: in 1990, Marico Industries entered into a Registered Users Agreement with Bombay Oil Industries (BOIL) for use of the Saffola brand, and by 1993 Saffola was being manufactured in Marico’s own factories. In 1999, Marico and BOIL signed a pact leading to a complete handover of both Parachute and Saffola to Marico. Harsh Mariwala, who had joined the family business in 1971, led Marico through this period as Managing Director, and the company made its initial public offer in March 1996.

Within the premium refined edible oil segment, Saffola is reported to have held a dominant position for an extended period. Marico reportedly maintained market leadership in the super-premium refined edible oil segment with Saffola until 2019, with a market share cited at around 73%. This figure is carried in secondary industry commentary rather than a primary Marico disclosure, and should be read with that caveat.

Brand Situation Prior to Campaign

Saffola’s early positioning was built almost entirely on therapeutic association. Its typical customer in this period was a mid-aged urban male suffering from heart ailments, who had switched to Saffola on a doctor’s recommendation; the brand was consequently seen as a scary, therapeutic, medicinal item, and in many households the affected family member’s food was cooked separately in Saffola while the rest of the family continued using regular oil. This created a paradox that is documented across multiple case analyses of the brand: strong awareness coexisting with weak emotional affinity. A brand audit at the time found that Saffola’s personality was viewed as detached and authoritative, devoid of emotional attachment, even though brand recall remained high. insideiiminsideiim

The commercial consequence of this positioning was a structurally capped addressable market. A brand associated with existing cardiac patients could only ever reach the subset of the population already diagnosed or symptomatic, rather than the much larger population of health-conscious or health-anxious consumers who had not yet experienced illness. Marico’s response, as documented in its own repositioning case materials, was to treat this as a deliberate strategic problem to be solved rather than an inevitability of the health-oil category. By March 2004, Marico’s marketing team responsible for the Saffola brand was examining a proposed advertising campaign specifically intended to reposition the brand in the minds of consumers, at a time when Saffola was already the flagship brand in Marico’s edible oils category and commanded a premium in a highly price-competitive Indian oils market. cliffsnotes

Strategic Objective

The documented objective of this phase of brand work was to shift Saffola from a narrow, curative health association toward a broader, preventive wellness association that could plausibly include any household, not only those managing existing heart disease. Marico’s own efforts, as described in published brand case analysis, aimed to shed the brand’s older perception and reposition Saffola around more optimistic, positive attributes such as care, happiness and insurance against future risk, arriving at a positioning summarised as “the first step towards a healthy living.” Campaigns built around this idea, including the widely cited “Chaar Kadam Aage” (“Four Steps Ahead”) work, drove home the point that the least a consumer could do to show care for a loved one’s health was to use a genuinely healthy cooking oil.

This reframing had a clear commercial logic. A curative brand, by definition, addresses only the market of existing patients. A preventive brand addresses the much larger population of people who are not yet ill but are anxious about becoming so a population that, in a country with rising rates of lifestyle-linked disease, is effectively the entire adult household-purchasing base. The strategic objective was therefore not simply a change in tone of advertising, but an attempt to redefine the category Saffola competed in: from an edible oil brand to a heart-health platform that happened to sell edible oil as its anchor product.

Campaign Architecture & Execution

Marico institutionalised this shift beyond conventional product advertising through a dedicated, brand-owned health platform. In 2005, Saffola launched Saffolalife.com, a service focused on the health and nutrition aspects of preventive healthcare. Marico’s own press communications consistently describe this initiative in specific terms: Saffolalife is characterised as “a not-for-profit initiative by Marico Limited,” built on the company’s stated commitment to creating a “Heart Healthy India.

The execution architecture that followed was built around a recurring calendar anchor World Heart Day, observed globally on 29 September rather than a single campaign burst. This gave Saffola an annually renewing reason to communicate about heart health independent of any single product launch, and over multiple years the content strategy evolved rather than repeated:

In 2018, the Saffolalife World Heart Day campaign was built around a specific health-literacy gap. The campaign, conceptualised by McCann Mumbai, combined a digital film with a research study on the “Impact of belly fat on heart health,” reporting that 67% of Indians with belly fat were found to be at heart risk and that 83% of Indians at heart risk due to belly fat did not consider belly fat a key risk factor. Then Marico CMO Anuradha Aggarwal framed the effort as an attempt to “build a Heart Healthy India by encouraging people to take charge of their heart health through small yet impactful measures.

In 2019, the architecture shifted from awareness content to an interactive diagnostic tool. The World Heart Day campaign that year, created with Mullen Lowe/Mullen Lintas, released a study conducted in association with Nielsen and was built around the idea that small, commonly ignored lifestyle behaviours carry real heart-health consequences. Alongside the films, Saffolalife introduced an online tool called “Heart Ka Exam,” designed as a report card for the user’s heart condition, nudging people to take the test and learn how habits such as inadequate sleep or belly fat affect heart health. Saffolalife also launched a “Healthy Lifestyle Index,” a tool correlating a lifestyle score to heart health, as part of a broader communication shift toward proactive rather than fear-based heart health messaging.

In 2020, the platform extended its target audience segmentation by gender. That year’s World Heart Day campaign, #CareForHerHeart, was built around the specific thesis that the everyday stress women experience has an adverse effect on heart health, and urged loved ones to prioritise women’s heart health. Then CMO Koshy George described Saffolalife as having “undertaken various initiatives aimed at encouraging people to adopt a proactive healthy lifestyle” as part of its ongoing commitment to a Heart Healthy India. Most recently, the platform has incorporated generative AI into its execution. In 2025, Marico launched “Heart to Heart Talk,” described as an AI-based World Heart Day campaign, intended to create what the company called “a moment of truth for consumers” rooted in self-reflection about daily habits. The campaign tied directly back to product substantiation, featuring Saffola Total formulated with Oryzanol, positioned as helping reduce cholesterol as the oil that supports consumers “every step of the way.” Ashish Goupal, CEO of Marico’s India core business, framed the campaign as an extension of a purpose the brand has held for decades, rather than a one-off activation.

Running parallel to this communications architecture was a portfolio-level execution strategy: broadening what “Saffola” as a masterbrand could credibly sell. Marico extended Saffola from oil into adjacent “preventive” categories over successive years entering salt in the early 2000s on the logic that, after tackling cholesterol through oil, the brand could extend into other heart-health-adjacent risk factors such as blood pressure, with the category head at the time noting that an estimated 100 million Indians suffer from hypertension. By FY2019-20, the Saffola family of sub-brands disclosed in Marico’s own stock-exchange filings included Saffola FITTIFY Gourmet, Saffola ImmuniVeda, Saffola Arogyam and Saffola Mealmaker, alongside core oils. By FY23, this had extended further into oats, honey, noodles, peanut butter, mayonnaise and ready-to-eat healthy snacking under the Saffola Munchie line.

Positioning & Consumer Insight

The consumer insight underlying this body of work is explicit in Marico’s own campaign materials: heart disease risk in India is widely perceived as a problem of visible illness, when in practice it is driven substantially by invisible, everyday, and commonly dismissed behaviours. The belly-fat study, the Heart Ka Exam tool, and the stress-focused #CareForHerHeart work are each built on a version of the same insight that consumers systematically underestimate the heart-health cost of routine behaviours (unmanaged body fat, inadequate sleep, chronic stress) because those behaviours do not feel medical in the way a cardiac diagnosis does. Former CMO Koshy George summarised the brand’s core challenge not as competition from other oil brands or newer “healthy” entrants, but as competition against consumer mindset itself, noting that only a small subset of people who are theoretically aware of heart risk actually take concrete steps to intervene.

This reframes Saffola’s positioning task as a behavioural, not informational, problem. Rather than simply stating that heart disease is dangerous a curative-era message that the brand had already tried and found limiting the preventive-era architecture consistently tries to convert abstract risk into a personalised, measurable, and actionable number (a belly-fat statistic, an exam score, a lifestyle index), which is a recognisable pattern from health-behaviour marketing more broadly: personalisation and quantification as levers for motivating action where generic risk messaging has failed.

Media & Channel Strategy

The World Heart Day platform has been consistently executed as a digital-first, agency-partnered program rather than a mass-media product campaign. The 2019 campaign’s television commercial, for instance, was released first on the brand’s YouTube channel ahead of wider distribution. Creative execution has been handled by established agency partners across different years McCann Mumbai conceptualised the 2018 digital film, while Mullen Lintas conceptualised the 2019 “Heart Ka Exam” work, indicating an agency relationship that has evolved over time rather than a single long-running creative partnership. Each year’s campaign has also been paired with a research or data release (the belly-fat study, the Nielsen-backed lifestyle study) used as earned-media and PR material, a mechanic that lets a relatively modest paid-media campaign generate ongoing news coverage in outlets such as Exchange4Media and Campaign India. No verified public information is available on specific media budgets allocated to the Saffolalife platform, reach or impression figures for individual World Heart Day campaigns, or paid-versus-earned media mix.

Business & Brand Outcomes

Separating brand-communication outcomes from category and portfolio outcomes is important, since Marico’s public disclosures report the latter far more consistently than the former.

At the masterbrand level, Marico’s own annual report materials state that Saffola’s addressable market, through its portfolio of healthy value-added food offerings, has been expanded to more than Rs 10,000 crore. The foods portfolio delivered 20% growth in FY23, closing near a Rs 600 crore revenue mark, with the company targeting roughly Rs 850 crore in FY24. Over the same period, the combined share of newer domestic portfolios foods, premium personal care and digital-first brands rose from 8% of domestic revenue in FY20 to 15% in FY23. By FY24, Marico had set a target of more than 20% CAGR for the foods business, aiming to double it by FY27, with foods and premium personal care together expected to reach roughly 25% of domestic revenue by FY27.

Within foods specifically, independent market-measurement data cited in Marico’s FY24 disclosures indicates category leadership has been achieved in at least one key sub-segment: Saffola Oats was reported as India’s No. 1 oats brand per Kantar Household Panel data, with Saffola Masala Oats also registering healthy, penetration-led growth. In the most recently disclosed quarterly results reviewed, the foods portfolio spanning Saffola Oats, Soya Chunks and Muesli expanded 43% year-on-year, crossing an annualised revenue run-rate of Rs 1,300 crore.

The core oils business, by contrast, has shown more volatility, and this volatility is itself instructive about the limits of brand positioning in a commodity-exposed category. In FY24, Saffola Edible Oils recorded low-single-digit volume growth in a year marked by a sharp decline in reported revenue, driven by multiple rounds of price corrections made in response to falling vegetable oil prices. In the most recent quarter reviewed, Saffola which makes up 16% of Marico’s domestic revenue experienced a high single-digit volume decline, even as Marico’s overall India revenue grew 21% and consolidated net profit rose 25% to Rs 630 crore. This divergence suggests that brand equity built on preventive-health positioning has been more durable and monetisable in the newer foods categories (oats, soya, muesli) than in the legacy super-premium oils segment, where price sensitivity and commodity input-cost swings continue to dominate volume and revenue outcomes regardless of brand narrative. Separately, Marico’s FY23 annual report disclosed that the Saffola franchise of super-premium refined edible oils contributed 23% of domestic revenue that year.

On marketing investment, Marico’s overall advertising spend rose 13% to Rs 952 crore in FY24, from Rs 842 crore in FY23, with foods and premium personal care brands cited as leading that increase. No verified public information is available on the specific advertising spend allocated to Saffola or the Saffolalife platform individually within this consolidated figure, nor on independently audited brand-health metrics (such as brand trust or purchase-intent scores) tied specifically to the World Heart Day campaigns.

Strategic Implications

Several transferable lessons can be drawn from Saffola’s documented trajectory, read strictly against the public record. First, a brand built on a narrow, curative health claim can be deliberately and durably repositioned around a broader preventive claim, but this appears to require sustained multi-year investment in an owned platform (Saffolalife, running continuously since 2005) rather than a single repositioning campaign; Marico’s own 2004 internal case materials describe this as a problem the organisation was actively working through, not one resolved by a single advertising burst.

Second, converting a preventive-health positioning into category-level business results appears to depend heavily on portfolio extension into categories where health claims translate more directly into product attributes consumers can evaluate at the shelf oats, soya, muesli rather than relying solely on the original oils category, where the brand’s reported performance has been more exposed to commodity price cycles than to narrative strength.

Third, pairing an emotionally resonant health message with a quantifiable, personalised diagnostic mechanic (a belly-fat statistic, a “Heart Ka Exam,” a lifestyle index score) appears to be a deliberate and recurring executional choice across multiple campaign years, suggesting Marico’s marketing team treats abstraction as the primary barrier to preventive health action, and personalisation/quantification as its most reliable countermeasure.

Fourth, the consistent use of a recurring calendar moment (World Heart Day) as an annual communications anchor, rather than only product-launch-driven advertising, allowed Saffola to institutionalise heart-health thought leadership as an ongoing editorial property rather than a series of disconnected campaigns a structure that appears to have given the brand continuous earned-media visibility over nearly two decades.

Fifth, and most important for interpretation of any preventive-health brand story: the public record available shows strong evidence of sustained positioning discipline and category/portfolio growth narrative from Marico, but does not provide independently verified data linking the Saffolalife campaigns causally to incremental oil or foods sales. The business outcomes documented (foods portfolio growth, Saffola Oats’ category leadership, overall revenue mix shift) are real and verifiable, but they reflect the combined effect of positioning, product innovation, distribution expansion and pricing strategy — not brand communication in isolation. Any strategic conclusion about the “preventive health” campaign’s standalone commercial effectiveness should be treated as an informed interpretation rather than a documented causal fact,

Discussion Questions

1. Marico treated Saffola’s “curative-to-preventive” repositioning as a multi-decade, platform-level commitment (Saffolalife, running since 2005) rather than a single campaign. What organisational and financial conditions make this kind of long-horizon brand investment viable, and when might it not be justified?

2. Saffola’s foods portfolio (oats, soya, muesli) has grown faster and more profitably in recent years than its legacy oils business, which remains exposed to commodity price volatility. What does this divergence suggest about where “preventive health” as a brand platform can and cannot protect a business from category-level economics?

3. Each year’s World Heart Day campaign pairs an emotional film with a quantified diagnostic tool or study (a belly-fat statistic, the Heart Ka Exam, a Healthy Lifestyle Index). Evaluate this as a recurring creative mechanic: what behavioural assumption is it built on, and what are its risks if the underlying data or tools are perceived as gimmicks rather than credible science?

4. Saffola extended its “heart health” platform into salt (addressing blood pressure) and later into a wide range of packaged foods. From a brand-extension standpoint, assess the logic of extending a single health-risk narrative (heart disease) across multiple, structurally different product categories.

5. The case notes that no verified public data isolates the sales impact of the Saffolalife campaigns specifically from other business drivers (pricing, distribution, product innovation). As an MBA marketing analyst, what metrics would you request from Marico to properly evaluate the standalone ROI of this campaign platform, and why are they unlikely to be publicly disclosed?